Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 May, 2018 15:43 IST
Lupin receives tentative USFDA nod for generic Locoid lotion
Source: IRIS | 12 Feb, 2018, 04.20PM
Comments  |  Post Comment

Pharma major Lupin announced that it has received tentative approval for its Hydrocortisone Butyrate Lotion, 0.1% from the United States Food and Drug Administration (FDA) to market a generic version of Precision Dermatology, Inc.'s Locoid Lotion, 0.1%.

Lupin's Hydrocortisone Butyrate Lotion, 0.1% is the generic equivalent of Precision Dermatology, Inc.'s Locoid Lotion, 0.1%. It is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

Hydrocortisone Butyrate Lotion, 0.1% had annual sales of approximate USD 16.1 million in the US (IQVIA MAT October 2017).

Shares of the company gained Rs 18.4, or 2.24%, to settle at Rs 839.30. The total volume of shares traded was 124,365 at the BSE (Monday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
NITI Aayog and ABB India partner to make India AI-Ready - 23-May-2018 15:39
TCS update on multi-year agreement with Transamerica - 23-May-2018 15:21
Tata Steel to raise Rs 165 bn debt to fund Bhushan Steel acquisition - 23-May-2018 11:18
DQ Entertainment signs exclusive deal with Chiliad Procons - 23-May-2018 11:09
Jain Irrigation to execute Rs 2.39 bn integrated drip irrigation project - 23-May-2018 11:01
Suven Life Sciences secures 2 overseas product patents - 23-May-2018 10:34
Yes Bank recovers Rs 1.84 bn from sale of Bhushan Steel to Tata Steel - 23-May-2018 10:08
Yes Bank recovers Rs 1.84 bn from sale of Bhushan Steel to Tata Steel - 23-May-2018 10:08
Larsen & Tubro bags order worth Rs 14.25 bn - 23-May-2018 10:03
Sun Pharma announces USFDA approval of YONSA - 23-May-2018 09:51
Cipla swings to profit in Jan-Mar quarter - 22-May-2018 16:24
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer